Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial

By Carr B.R.   Breslau N.A.   Peng N.   Adams-Huet B.   Bradshaw K.D.   Steinkampf M.P.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1216-1223

Elsevier

Access to resources Recommend Favorite

A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women

By Sator P.-G.   Sator M. O.   Schmidt J. B.   Nahavandi H.   Radakovic S.   Huber J. C.   Honigsmann H.  

Climacteric, Vol. 10, Iss. 4, 2007-08 ,pp. : 320-334

Informa Healthcare

Access to resources Recommend Favorite

Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and &unknown;add-back&unknown; therapy

By Murray S.C.   Muse K.N.  

Fertility and Sterility, Vol. 67, Iss. 2, 1997-02 ,pp. : 390-393

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial

By Vercellini P.   Trespidi L.   Zaina B.   Vicentini S.   Stellato G.   Crosignani P.G.  

Fertility and Sterility, Vol. 79, Iss. 6, 2003-06 ,pp. : 1390-1395

Elsevier

Access to resources Recommend Favorite

Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up

By Pierce S.J.   Gazvani M.R.   Farquharson R.G.  

Fertility and Sterility, Vol. 74, Iss. 5, 2000-11 ,pp. : 964-968

Elsevier

Access to resources Recommend Favorite